Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Active not recruiting 2

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other neoplasm 1Gynecologic 1Gastrointestinal 1

Conditions

Uterine Prolapse 1Uterine Cervical Neoplasms 1Precancerous Conditions 1Ovarian Neoplasms 1Menstruation Disturbances 1Leiomyoma 1Endometriosis 1Endometrial Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Adenomyosis 1

Interventions

pembrolizumab 279Carboplatin 214Cisplatin 145Gemcitabine 144Paclitaxel 142Bevacizumab 115Pemetrexed 112Docetaxel 100Oxaliplatin 78Dexamethasone 77durvalumab 76Fluorouracil 76atezolizumab 75Nivolumab 74Cyclophosphamide 74130-nm albumin-bound paclitaxel 71Fulvestrant 68Cetuximab 63Capecitabine 63Injections 61Leucovorin 60Rituximab 55fludarabine 50Lenalidomide 49venetoclax 43Prednisone 43Irinotecan 42enzalutamide 39Letrozole 39tislelizumab 37

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Robotic Surgical Procedures × 90 days × Clear all
NCT04403022 2026-06-03

da Vinci SP® Investigational Device Exemption Study in Colorectal Procedures

Intuitive Surgical

Phase NA Active not recruiting
60 enrolled 9 charts
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT07120945 2026-06-02

Embrace Gyn

Medtronic - MITG

Phase NA Active not recruiting
70 enrolled
GynecologicOther neoplasm

Uterine Cervical Neoplasms, Endometriosis, Leiomyoma, Menstruation Disturbances, Ovarian Neoplasms, Precancerous Conditions, Uterine Prolapse, Endometrial Neoplasms, Adenomyosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡